Headache and the risk of stroke

Current Atherosclerosis Reports

Volumn 6, Issue 4, 2004, Pages 320-325

  Jousilahti, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOT ALKALOID; ERGOTAMINE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

BRAIN INJURY; CHRONIC DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG USE; EPILEPTIC AURA; HEADACHE; HIGH RISK PATIENT; HUMAN; MIGRAINE; ORAL CONTRACEPTION; POPULATION RESEARCH; PREDICTION; PREMENOPAUSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STROKE; TREATMENT OUTCOME;

EID: 5444258873     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-004-0065-y     Document Type: Review

References (33)

1. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(suppl 7): 1-96.
2. Stewart WF, Shechter A, Rasmussen BK: Migraine prevalence. A review of population-based studies. Neurology 1994, 44(6 suppi 4): S17-S23.
3. Ferrari MD: Migraine. Lancet 1998, 351: 1043-1051.
4. Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991, 44: 1147-1157.
5. Sudlow CL, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997, 28: 491-499.
6. Marmot MG, Poulter NR: Primary prevention of stroke. Lancet 1992, 339: 344-347.
7. Hankey GJ: Role of lipid-modifying therapy in the prevention of initial and recurrent stroke. Curr Opin Lipidol 2002, 13: 645-651.
8. Bots ML, Elwood PC, Nikitin Y, et al.: Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002, 56(suppl 1): i19-i24.
9. Schwartz SM, Petitti DB, Siscovick DS, et al.: Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke 1998, 29: 2277-2284.
10. Collaborative Group for the Study of Stroke in Young Women: Oral contraceptives and stroke in young women: associated risk factors. JAMA 1975, 231: 718-722.
11. Marini C, Carolei A, Roberts RS, et al.: Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology 1993, 12: 70-81.
12. Buring JE, Hebert P, Romero J, et al.: Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995, 52: 129-134.
13. Tzourio C, Iglesias S, Hubert JB, et al.: Migraine and risk of ischaemic stroke: a case-control study. BMJ 1993, 307: 289-292.
14. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al.: Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995, 310: 830-833.
15. Lidegaard O: Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol 1995, 102: 153-159.
16. Carolei A, Marini C: Stroke in users of low-dose oral contraceptives. N Engl J Med 1996, 335: 1767-1768.
17. Merikangas KR, Fenton BT, Cheng SH, et al.: Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997, 54: 362-368.
18. Chang CL, Donaghy M, Poulter N: Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999, 318: 13-18.
19. Tietjen CE: The relationship of migraine and stroke. Neuroepidemiology 2000, 19: 13-19.
20. Jousilahti P, Tuomilehto J, Rastenyte D, Vartiainen E: Headache and the risk of stroke: a prospective observational cohort study among 35,056 Finnish men and women. Arch Intern Med 2003, 163: 1058-1062.
21. Henrich JB, Horwitz RI: A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989, 42: 773-780.
22. Milhaud D, Bogousslavsky J, van Melle G, Liot P: Ischemic stroke and active migraine. Neurology 2001, 57: 1805-1811.
23. Anzola GP, Magoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52: 1622-1625.
24. Silvestrini M, Cupini LM, Matteis M, et al.: Migraine in patients with stroke and antiphospholipid antibodies. Headache 1993, 33: 421-426.
25. Ojaimi J, Katsabanis S, Bower S, et al.: Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis 1998, 8: 102-106.
26. D'Amico D, Moschiano F, Leone M, et al.: Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 1998, 18: 618-621; discussion 591.
27. Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291: 427-434.
28. Biousse V, D'Anglejan-Chatillon J, Massiou H, Bousser MG: Head pain in non-traumatic carotid artery dissection: a series of 65 patients. Cephalalgia 1994, 14: 33-36.
29. Bulpitt CJ, Dollery CT, Carne S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976, 38: 121-128.
30. Kivipelto M, Helkala EL, Laakso MP, et al.: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322: 1447-1451.
31. Kivipelto M, Soininen H, Tuomilehto J: Hypertension and white matter lesions of the brain. J Hypertens 2002, 20: 387-389.
32. Hankey GJ, Eikelboom JW: Aspirin for the primary prevention of cardiovascular events. Med J Aust 2002, 177: 343-344.
33. Alberts MJ, Easton JD: Clopidogrel plus aspirin for stroke prevention. Stroke 2002, 33: 2546-2547; author reply 2546-2547.